Vivacy joins forces with Shanghai Pharmaceuticals for a new breakthrough in the Chinese aesthetics market

To strengthen its international development, Vivacy, a company present in the Vintage Altaroc Odyssey 2022, has signed a strategic distribution agreement with Shanghai Pharmaceuticals, China's largest importer of medicines and a leading player in the pharmaceutical field. This strategic partnership with the Chinese market comes at a time when Vivacy is continuing to expand in a sector driven by growing global demand.

An alliance to consolidate Vivacy's presence in Asia

Thanks to this partnership with Shanghai Pharmaceuticals, Vivacy is closer to Chinese professionals and consumers to meet the growing demand for quality medical aesthetic solutions. This collaboration enables Vivacy to extend its expertise and quality standards beyond its traditional markets, as the appeal of aesthetic care continues to grow in Asia.

With a solid reputation built on high-quality products and a patient-oriented approach, Vivacy sees this expansion as an opportunity to play an active part in China's aesthetic revolution. Shanghai Pharmaceuticals, already well established in this market, will facilitate the introduction of Vivacy's hyaluronic acid range, guaranteeing robust local support and optimal access to products.